Indication
Nonfunctional neuroendocrine tumor of lung origin
A nonfunctional neuroendocrine tumor of lung origin is a neoplasm arising from the neuroendocrine cells of the bronchopulmonary system that does not secrete clinically significant levels of hormones or vasoactive peptides. Read more about Nonfunctional neuroendocrine tumor of lung origin
7 drugs 7 manufacturers
Drugs that treat it
Common Nonfunctional neuroendocrine tumor of lung origin therapies.
TORPENZ (everolimus)
EVEROLIMUS
EVEROLIMUS
AFINITOR (everolimus)
EVEROLIMUS
YULITHIRA (everolimus)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA nonfunctional neuroendocrine tumor of lung origin is a neoplasm arising from the neuroendocrine cells of the bronchopulmonary system that does not secrete clinically significant levels of hormones or vasoactive peptides.
Primarily affecting adults, these tumors—encompassing typical and atypical pulmonary carcinoids—lack the paraneoplastic or hypersecretory endocrine syndromes, such as carcinoid syndrome or ectopic hormone secretion, seen in functional subtypes.
Patients frequently remain asymptomatic in early stages or present later with local mass effects, including cough, hemoptysis, dyspnea, wheezing, and post-obstructive atelectasis or pneumonia.
Histologically, they exhibit characteristic neuroendocrine architecture and markers such as synaptophysin and chromogranin A, with biological behavior ranging from indolent to metastatic based on mitotic rate and the presence of necrosis.
- nih.gov
A nonfunctional neuroendocrine tumor of lung origin is a neoplasm arising from the neuroendocrine cells of the bronchopulmonary system that does not secrete clinically significant levels of hormones or vasoactive peptides
- netrf.org
A nonfunctional neuroendocrine tumor of lung origin is a neoplasm arising from the neuroendocrine cells of the bronchopulmonary system that does not secrete clinically significant levels of hormones or vasoactive peptides Primarily affecting adults, these tumors—encompassing typical and atypical pulmonary carcinoids—lack the paraneoplastic or hypersecretory endocrine syndromes, such as carcinoid syndrome or ectopic hormone secretion, seen in functional subtypes Patients frequently remain asympto...
- nih.gov
Primarily affecting adults, these tumors—encompassing typical and atypical pulmonary carcinoids—lack the paraneoplastic or hypersecretory endocrine syndromes, such as carcinoid syndrome or ectopic hormone secretion, seen in functional subtypes Histologically, they exhibit characteristic neuroendocrine architecture and markers such as synaptophysin and chromogranin A, with biological behavior ranging from indolent to metastatic based on mitotic rate and the presence of necrosis
- merckmanuals.com
Primarily affecting adults, these tumors—encompassing typical and atypical pulmonary carcinoids—lack the paraneoplastic or hypersecretory endocrine syndromes, such as carcinoid syndrome or ectopic hormone secretion, seen in functional subtypes Patients frequently remain asymptomatic in early stages or present later with local mass effects, including cough, hemoptysis, dyspnea, wheezing, and post-obstructive atelectasis or pneumonia
- cancer.gov
Patients frequently remain asymptomatic in early stages or present later with local mass effects, including cough, hemoptysis, dyspnea, wheezing, and post-obstructive atelectasis or pneumonia
- nih.gov
Histologically, they exhibit characteristic neuroendocrine architecture and markers such as synaptophysin and chromogranin A, with biological behavior ranging from indolent to metastatic based on mitotic rate and the presence of necrosis
Personalize your experience
Follow Nonfunctional neuroendocrine tumor of lung origin and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.